Abbott Laboratories (ABT) Shares are Down -2.85%

Abbott Laboratories (ABT) : During the past 4 weeks, traders have been relatively bearish on Abbott Laboratories (ABT), hence the stock is down -3.75% when compared to the S&P 500 during the same period. However, in the past 1 week, the selling of the stock is down by -2.21% relative to the S&P 500. The 4-week change in the price of the stock is -3.96% and the stock has fallen -2.85% in the past 1 week.

For the current week, the company shares have a recommendation consensus of Buy. The stock has recorded a twenty day Moving Average of 3.69% and the fifty day Moving Average is 1.89%. Abbott Laboratories is up 10.04% in the last three month period. Year-to-Date the stock performance stands at -2.51%.

Abbott Laboratories (ABT) stock is expected to deviate a maximum of $1.78 from the average target price of $48.82 for the short term period. 11 Street Experts have initiated coverage on the stock with the most promising target being $52 and the most muted being $45.


Abbott Laboratories (NYSE:ABT): stock turned positive on Friday. Though the stock opened at $42.72, the bulls momentum made the stock top out at $43.28 level for the day. The stock recorded a low of $42.09 and closed the trading day at $42.98, in the green by 0.33%. The total traded volume for the day was 18,670,546. The stock had closed at $42.84 in the previous days trading.

Abbott Laboratories (Abbott) is engaged in the discovery, development, manufacture and sale of a range of health care products. Abbott operates in four business segments: Established Pharmaceutical Products, Diagnostic Products, Nutritional Products, and Vascular Products. The Established Pharmaceutical Products segment includes the international sales of a line of branded generic pharmaceutical products. The Diagnostic Products segment includes the sales of a line of adult and pediatric nutritional products. The Nutritional Products includes the sales of diagnostic systems and tests for blood banks, hospitals, commercial laboratories and alternate-care testing sites. The Vascular Products includes the sales of coronary, endovascular, structural heart, vessel closure and other medical device products.

Comments (0)

Leave a Reply

Your email address will not be published. Required fields are marked *

Get Pre-Market Alerts!

Get Pre-Market Analysts' Upgrades, Downgrades, Earnings & Initiations with our FREE daily email newsletter.